Clinical Trials
4 trialsNCT03437941 2026-05-15
Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
Corcept Therapeutics
Phase 1/2 Terminated
NCT07190300 2026-05-12
TulmiSTAR-02
Novartis
Phase 1/2 Recruiting
NCT07336446 2026-05-01
ANDROMEDA
AstraZeneca
Phase 1/2 Recruiting
NCT00878436 2018-02-07
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
NYU Langone Health
Phase 1/2 Completed